Stryker (SYK) Cash from Restructuring (2009)

Stryker (SYK) posted quarterly Cash from Restructuring of -$96.8 million for Q4 2009, down 300.0% on a QoQ basis from $48.4 million in Q3 2009.

Stryker (SYK) Cash from Restructuring (2009) Analysis & Trends

Stryker has reported Cash from Restructuring for 1 years, with the latest figure at -$96.8 million in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Zimmer Biomet Holdings	19.04 Bn	18.63 Bn	1.54 Bn

Download Data

Date	Value
Dec 31, 2009	-96.80 Mn
Sep 30, 2009	48.40 Mn